Acinetobacter baumannii has emerged as a major cause of healthcare-associated
infections. Controversy exists as to whether antimicrobial resistance increases the risk of …

Carbapenems are considered the treatment of choice for Acinetobacter baumannii
infections. Many facilities implement preventive measures toward only carbapenem-resistant …

BACKGROUND: Risk factors and outcome in patients who acquire nosocomial infections
due to carbapenem-resistant Acinetobacter baumannii (CRAB) are rarely investigated …

Background Carbapenem-resistant Acinetobacter baumannii (CRAB) tops the list of threats
to human health. Studies exploring predictors of mortality in patients with CRAB infection …

Abstract Background Carbapenem-resistant (CR) Acinetobacter baumannii is a concerning
pathogen in the USA and worldwide. Methods To assess the comparative burden of CR vs …

Nosocomial Acinetobacter baumannii bloodstream infections occur with significant
prevalence and mortality. The relationship between carbapenem resistance in A. baumannii …

BACKGROUND: It is still controversial whether carbapenem-resistant Acinetobacter
baumannii (CRAB) is an independent risk factor for mortality. This study aimed to determine …

Acinetobacter baumannii has become a leading cause of bloodstream infections (BSI) in
health care settings. Although the incidence of infection with carbapenem-and ampicillin …

Objective. To investigate the impact of antimicrobial resistance on clinical and economic
outcomes among hospitalized patients with multidrug-resistant (MDR) Acinetobacter …

Background Acinetobacter baumannii, an opportunistic nosocomial pathogen that can
cause significant morbidity and mortality, has emerged as a worldwide problem. The aim of …